Asia Pacific Anaphylaxis Treatment Market
The Asia Pacific Anaphylaxis Treatment Market size was valued at US$ 350.7 Mn in 2021 and is projected to reach US$ 664.0 Mn by 2028, growing at a CAGR of 9.6% during 2021 - 2028.
Report Coverage
- Medication Type: Epinephrine, Antihistamines, Steroids, Beta-Agonist
- Route of Administration: Oral, Parenteral
- Allergy Type: Food Allergy, Medications, Insect Stings
- Distribution Channel: Hospital Pharmacies, Retail Sales
US$ 350.7 Mn
Market size in 2021
US$ 664.0 Mn
Market Size by 2028
9.6%
CAGR, 2021 - 2028
2022-2028
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Anaphylaxis Treatment Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Anaphylaxis Treatment Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Anaphylaxis Treatment Market Regional Analysis
6.2 Asia Pacific Anaphylaxis Treatment Market Revenue 2019-2028 (US$ Million)
6.3 Asia Pacific Anaphylaxis Treatment Market Forecast Analysis
7. Asia Pacific Anaphylaxis Treatment Market Analysis – by Medication Type
7.1 Epinephrine
- 7.1.1 Overview
- 7.1.2 Epinephrine: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.2 Antihistamines
- 7.2.1 Overview
- 7.2.2 Antihistamines: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.3 Steroids
- 7.3.1 Overview
- 7.3.2 Steroids: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
7.4 Beta-Agonist
- 7.4.1 Overview
- 7.4.2 Beta-Agonist: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8. Asia Pacific Anaphylaxis Treatment Market Analysis – by Route of Administration
8.1 Oral
- 8.1.1 Overview
- 8.1.2 Oral: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
8.2 Parenteral
- 8.2.1 Overview
- 8.2.2 Parenteral: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9. Asia Pacific Anaphylaxis Treatment Market Analysis – by Allergy Type
9.1 Food Allergy
- 9.1.1 Overview
- 9.1.2 Food Allergy: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.2 Medications
- 9.2.1 Overview
- 9.2.2 Medications: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
9.3 Insect Stings
- 9.3.1 Overview
- 9.3.2 Insect Stings: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
10. Asia Pacific Anaphylaxis Treatment Market Analysis – by Distribution Channel
10.1 Hospital Pharmacies
- 10.1.1 Overview
- 10.1.2 Hospital Pharmacies: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
10.2 Retail Sales
- 10.2.1 Overview
- 10.2.2 Retail Sales: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast, 2019-2028 (US$ Million)
11. Asia Pacific Anaphylaxis Treatment Market – Asia-Pacific Analysis
11.1 Overview
11.2 Asia-Pacific- 11.2.1 Asia Pacific Anaphylaxis Treatment Market Breakdown, by Key Country, 2022 and 2028 (%)
- 11.2.1.1 Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast Analysis – by Country
- 11.2.1.1 China: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.1.1 China: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Medication Type
- 11.2.1.1.2 China: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Route of Administration
- 11.2.1.1.3 China: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Allergy Type
- 11.2.1.1.4 China: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Distribution Channel
- 11.2.1.2 India: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.2.1 India: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Medication Type
- 11.2.1.2.2 India: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Route of Administration
- 11.2.1.2.3 India: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Allergy Type
- 11.2.1.2.4 India: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Distribution Channel
- 11.2.1.3 Japan: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.3.1 Japan: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Medication Type
- 11.2.1.3.2 Japan: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Route of Administration
- 11.2.1.3.3 Japan: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Allergy Type
- 11.2.1.3.4 Japan: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Distribution Channel
- 11.2.1.4 Australia: Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.4.1 Australia: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Medication Type
- 11.2.1.4.2 Australia: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Route of Administration
- 11.2.1.4.3 Australia: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Allergy Type
- 11.2.1.4.4 Australia: Asia Pacific Anaphylaxis Treatment Market Breakdown, by Distribution Channel
- 11.2.1.5 Rest of Asia-Pacific : Asia Pacific Anaphylaxis Treatment Market – Revenue and Forecast to 2028 (US$ Million)
- 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Anaphylaxis Treatment Market Breakdown, by Medication Type
- 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Anaphylaxis Treatment Market Breakdown, by Route of Administration
- 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Anaphylaxis Treatment Market Breakdown, by Allergy Type
- 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Anaphylaxis Treatment Market Breakdown, by Distribution Channel
12. Competitive Landscape
12.1 Heat Map Analysis
12.2 Company Positioning and Concentration
13. Industry Landscape
13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments
14. Company Profiles
14.1 Amneal Pharmaceuticals Inc.
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Mylan N.V.
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Abbott
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Pfizer Inc.
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Glaxosmithkline Plc.,
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Merck And Co., Inc.
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Teva Pharmaceutical Industries Ltd.
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 ALK-ABELLó
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
15. Appendix
15.1 About Business Market Insights
15.2 List of Abbreviations
Access the Full A Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
